| Code | 7992E | ||||||||||
| MA number | 59/0293/24-S | ||||||||||
| Product Form: | tbl flm 60x30 mg (blis.PVC/PCTFE/PVC - Al/PET/papier) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | TEVA Pharmaceuticals Slovakia s.r.o., Slovakia | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 25.11.2024 |
| Validity: | 25.11.2029 |
| SPC: |
SPC_Apremilast Teva_11 2024.pdf
|
| PIL: |
PIL_Apremilast Teva_11 2024.pdf
|
| Safety feature | Yes |
| Data update: | 02.12.2024 |
